MiRNA-based molecular therapy for Right ventricular cardiomyopathy: Repressor-element-1-silencing transcription factor suppresses arrhythmogenic right ventricular cardiomyopathy via down regulation of its target gene, 22/February/2015, 12.09 am

AntagomiR-based theapy for wound repair: AntagomiR-196 promotes epithelial wound repair via up regulation of its target gene, 21/February/2015, 23.43
February 21, 2015
Molecular based therapy for NIDDM: Jagged1 inhibits gluconeogenesis and hyperglycemia via up regulation of CyclinD1, 22/February/2014, 9.13 am
February 22, 2015
Show all

A recent study from the Ludwig Institute for Cancer Research Limited, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7DQ, United Kingdom shows that iASPP, a previously unidentified regulator of desmosomes, prevents arrhythmogenic right ventricular cardiomyopathy  ….” This study was published in the 17 February  2015 issue of Proc Natl Acad Sci U S A by Prof Xin Lu, Dr. Notari M, and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: MiRNA-based molecular therapy for Right ventricular cardiomyopathy: Repressor-element-1-silencing transcription factor suppresses arrhythmogenic right ventricular cardiomyopathy via down regulation of its target gene.  Thus, pharmacological formulations encompassing “Repressor-element-1-silencing transcription factor activators” may be used to inhibit arrhythmogenic right ventricular cardiomyopathy

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, MiRNA-based molecular therapy for Right ventricular cardiomyopathy: Repressor-element-1-silencing transcription factor suppresses arrhythmogenic right ventricular cardiomyopathy via down regulation of its target gene, 22/February/2015,  12.10 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Amount: $ 500*

Undisclosed information: How Repressor-element-1-silencing transcription factor suppresses arrhythmogenic right ventricular cardiomyopathy

Comments are closed.